Abstract:Objective: To investigate the change of innate lymphoid cells (ILC) subsets in peripheral blood and ascites in liver cirrhotic patients complicated with spontaneous bacterial peritonitis (SBP). Methods: The data of 62 patients with liver cirrhosis admited to the Zhumadian Central Hospital from November 2019 to November 2020 were analyzed. Among them, 41 cases were complicated with untainted ascites (untainted ascites group), while the other 21 cases were complicated with SBP (SBP group). Meanwhile, 20 cases of controls who received healthy examination in the same period were also enrolled (control group). Peripheral blood mononuclear cell (PBMC) was isolated from peripheral blood of all patients and controls. Mononuclear cell in ascites was isolated from patients with liver cirrhosis. The percentage of ILC1, ILC2, and ILC3 subsets in PBMC and mononuclear cell in ascites were measured by flow cytometry. CD3-CD19-CD20-CD14- cells (lin-cells) were purified from ascites and were stimulated with lipopolysaccharide (LPS) for 24 h. The transcription factor T-bet, GATA3, and RORγt mRNA relative level in lin-cells was semi-quantified by real-time PCR. Cytokine level in the supernatants was measured by enzyme linked immunosorbent assay. Differences of ILC subsets in peripheral blood and ascites were compared among groups. Results: There were twenty-nine males and twelve females in untainted ascites group, aged M(Q1,Q3) 49(33, 78) years. There were twelve males and nine females in SBP group, aged 50(37, 76) years. There were eleven males and nine females in control group, aged 48(32, 69) years. lin-CD45+CD161+CD127+ ILC cells could be detected in both peripheral blood and ascites. There was no significant difference in total ILC percentage within PBMC among untainted ascites group, SBP group, and control group (P=0.235). There was also no significant difference of total ILC percentage within mononuclear cells in ascites between untainted ascites group and SBP group (P=0.232). The differences were not statistically significant of peripheral CD117-CRTh2-ILC1, CRTh2+ILC2, or CD117+CRTh2-ILC3 within peripheral ILC among untainted ascites group, SBP group, and control group (all P>0.05). ILC1 percentage in ascites was up-regulated in SBP group compared with untainted ascites group (35.69%±3.39% vs 26.40%±3.85%, P<0.001), while ILC2 in ascites was down-regulated in SBP group (36.83%±7.70% vs 48.35%±9.45%, P<0.001). There was no statistical difference in ILC3 percentage in ascites between the two groups (P=0.230). T-bet mRNA relative level and IFN-γ production by lin- cells from ascites were elevated in response to LPS stimulation in SBP group compared with untainted ascites group (both P<0.001). GATA3 mRNA relative level and IL-5/IL-13 secretion by lin-cells from ascites were reduced in SBP group compared with untainted ascites group (both P<0.05). There was no significant difference of RORγt mRNA relative level or IL-17/IL-22 expression between the two groups (both P>0.05). Conclusion: Peripheral ILC subsets do not change in liver cirrhosis patients with SBP. ILC1 percentage is up-regulated, and ILC2 percentage is down-regulated in ascites in liver cirrhosis patients with SBP.

Effect of ascites ultrafiltration-concentration back-transfusion treatment on the natural killer cells (NKT) and renal-angiotensin II-aldosterone system (RAAS) for patients with cirrhotic refractory ascites

Nursing Experience of 61 Patients with Hepatic Cirrhosis Treated by Transfusion of Ultrafiltrated and Concentrated Self-Ascites

Effect of andrographitis on intestinal bacterial overgrowth,bacterial translocation and intestinal permeability in cirrhotic rats

Study of Ascitic-Concentrated Bacteria-Filtered Intravenous Re-Transfusion (ABR) to Treat Patients with Peritonitis of Schistosoma Cirrhosis

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Clinical Application of Angiotensin Receptor Blockers in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.

NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response

Double Ascites Ultrafiltration and Reinfusion into Abdominal Cavity of Hepatocirrhosis Patients with Refractory Ascites Combined with Spontaneous Bacterial Peritonitis

Study on the relationship between liver cirrhosis ascites and plasma sodium

41 cases of ascites reinfusion ultrafiltration combined dopamine and furosemide treatment of liver cirrhosis with refractory ascites analysis

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

[Change of innate lymphoid cell subsets in peripheral bloods and ascites in liver cirrhotic patients complicated with spontaneous bacterial peritonitis].

Application Value of High-Quality Nursing Intervention in Patients with Cirrhotic Ascites

Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites

Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure

[Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis]

Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C

Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression